Astellas builds its R&D footprint in Cambridge/Boston with an add-on for labs, offices

Bioregnum Opinion Column by John Carroll

Astellas is snapping in another piece of the real estate puzzle for its global R&D reorganization.

Just as it wraps one project to piece together its parts in the Bay Area, the Japanese pharma player has found a…
Click here to view original post